Study detail
Recruiting
SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Mayo Clinic
Summary
This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Detailed criteria
Inclusion Criteria: * Age \>= 18 years * Diagnosis of MM or AL based on IMWG diagnostic criteria * Planned to start a new treatment within 14 days (+/-7 days) * Able to provide written informed consent Exclusion Criteria: * Not able to give informed consent
Interventions
- OtherNon-Interventional Study
Non-interventional study
Location
- Mayo Clinic in RochesterRochester, Minnesota